GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Artesunate & Amodiaquine Tablets 50mg+135mg
C)Artesunate & Amodiaquine Tablets 100mg+270mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated tablet contains:
Artesunate…………………………………………..25mg
Amodiaquine Hydrochloride Equivalent to Amodiaquine Base………….67.5mg
Excipients……………………………………………..q.s
Colour: Ferric oxide Red
B) Artesunate & Amodiaquine Tablets 50mg +135mg
Each uncoated tablet contains:
Artesunate…………………………………………..50mg
Amodiaquine Hydrochloride Equivalent to Amodiaquine Base………….135mg
Excipients……………………………………………..q.s
Colour: Ferric oxide Yellow
C) Artesunate & Amodiaquine Tablets 100mg+270mg
Each uncoated tablet contains:
Artesunate…………………………………………….100mg
Amodiaquine Hydrochloride Equivalent to Amodiaquine Base……………270mg
Excipients………………………………………………q.s
Colour: Ferric oxide Black
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Dosage: As directed by the Physician
Attach dispensing label as per end country.
Artesunate & Amodiaquine Tablets 25mg+67.5mg Technical Specification:
| Product Name: | Artesunate & Amodiaquine Tablets |
| Brand Name: | Generic |
| Strength: | (25mg+67.5mg), (50mg+135mg), (100mg+270mg) |
| Dosage Form: | Tablets (Uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antimalarial |
| Indication: | Artesunate & Amodiaquine is a medication used for the treatment of malaria. |
| Storage: | Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Artesunate & Amodiaquine Tablets 25mg+67.5mg
- Artesunate & Amodiaquine Tablets 50mg+135mg
- Artesunate & Amodiaquine Tablets 100mg+270mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Artesunate & Amodiaquine Tablets 25mg+67.5mg
Each uncoated tablet contains:
Artesunate…………………………………………..25mg
Amodiaquine Hydrochloride
Equivalent to Amodiaquine Base…………….…….67.5mg
Excipients……………………………………………q.s.
Colour: Ferric oxide Red - Artesunate & Amodiaquine Tablets 50mg +135mg
Each uncoated tablet contains:
Artesunate…………………………………………..50mg
Amodiaquine Hydrochloride
Equivalent to Amodiaquine Base………………..135mg
Excipients…………………………………….……..q.s.
Colour: Ferric oxide Yellow
- Artesunate & Amodiaquine Tablets 100mg+270mg
Each uncoated tablet contains:
Artesunate…………………………………………….100mg
Amodiaquine Hydrochloride
Equivalent to Amodiaquine Base……………270mg
Excipients……………………………………………… q.s
Colour: Ferric oxide Black
THERAPEUTIC INDICATIONS:
Artesunate & amodiaquine is a medication used for the treatment of malaria. It is a fixed-dose combination of artesunate and amodiaquine. Specifically it recommended for acute uncomplicated Plasmodium falciparum malaria.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Dosage: As directed by the Physician.
Attach dispensing label as per end country.


















